Alternative Response Criteria (Choi, European Association for the Study of the Liver, and Modified Response Evaluation Criteria in Solid Tumors [RECIST]) Versus RECIST 1.1 in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib

INTRODUCTION. Response Evaluation Criteria in Solid Tumors, version 1.1 (RECIST 1.1), may underestimate activity and does not predict survival in patients with hepatocellular carcinoma (HCC) treated with sorafenib. This study assessed the value of alternative radiological criteria to evaluate respon...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ronot, Maxime, Bouattour, Mohamed, Wassermann, Johanna, Bruno, Onorina, Dreyer, Chantal, Larroque, Béatrice, Castera, Laurent, Vilgrain, Valérie, Belghiti, Jacques, Raymond, Eric, Faivre, Sandrine
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2014
Assuntos:
Hepatobiliary
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3983809/
https://ncbi.nlm.nih.gov/pubmed/24652387
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2013-0114
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados